Raptor Pharmaceutical Corp Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets
Raptor Pharmaceutical Corp had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets of $171.00 million as of 2016-06-30, per its 10-Q filed 2016-08-04.
Discontinued › Notes › Business Combinations › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets · last filed 2016-08-04
- 2016-06-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets $171.00M.
- 2016-03-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets $171.00M.
- 2015-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets $210.60M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets |
|---|---|
| 2016-06-30 | $171.00M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $171.00M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $210.60M 10-Q · filed 2016-08-04 |